TABLE2.
Category | Definition | Characteristics |
---|---|---|
PVs | Variants for which there is a strong genetic evidence for their involvement in the pathogenesis of HCM |
|
LPVs | As for PVs, except that genetic evidence for their involvement in the pathogenesis of HCM is less robust |
|
Functional variants with undefined clinical significance | Variants affect gene expression and/or protein function but are not associated with a clinical phenotype |
|
Variants with unknown significance | Undefined functional or clinical significance |
|
Likely benign variants | These variants are not expected to cause discernible phenotypic effects. They might have modest effects on gene expression but are not related to HCM |
|
Benign variants | Variants with no discernible functional, biological, or clinical effects |
|
Abbreviations:
PVs: Pathogenic variants; LPVs: Likely pathogenic variants; LoF: Predicted loss of function; CADD: Combined Annotated Dependent Depletion, which is a score calculated upon integration of more than 60 genomic features of single nucleotide variants and indels.